0
June 2012, Vol 130, No. 6 >

Full Content is available to subscribers

Subscribe/Learn More
Letters | June 2012

Update on Risk of Endophthalmitis After Intravitreal Drug Injections and Potential Impact of Elimination of Topical Antibiotics

Abdhish R. Bhavsar, MD; Cynthia R. Stockdale, MSPH; Frederick L. Ferris, MD; Alexander J. Brucker, MD; Neil M. Bressler, MD; Adam R. Glassman, MS; for the Diabetic Retinopathy Clinical Research Network
Arch Ophthalmol. 2012;130(6):809-810. doi:10.1001/archophthalmol.2012.227.
Text Size: A A A
Published online
Article
Tables
References
Comments (1)

Extract

Previously, the Diabetic Retinopathy Clinical Research Network reported a low rate of endophthalmitis achieved after intravitreal injection via a protocol requiring topical povidone-iodine, a sterile eyelid speculum, and topical anesthetic and not requiring topical antibiotics, sterile gloves, or a sterile drape.1 These results included 3838 injections of either ranibizumab or preservative-free triamcinolone acetonide. No antibiotics were given either before or after the injections in 1276 eyes. Of 3226 ranibizumab injections given between 2 Diabetic Retinopathy Clinical Research Network randomized trials, 3 cases of endophthalmitis occurred, all in eyes receiving topical antibiotics for several days after the injection.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment
Endophthalmitis in intravitral injections
Posted on July 22, 2012
Ramesh Sivaraj
Heart of England NHS Foundation Trust
Conflict of Interest: None Declared
Dear Dr Bhavsar et al,Thank you for your article. I was wondering if you encountered any patients with iodine allergy as these patients cannot have povidone prophylaxis preceding an intravitreal injection. There are some reports mentioning documented iodine allergy is not a contraindication for povidone use1. Is there a subgroup of your patients which did not receive povidone and if so did that influence the incidence of endophthalmitis.1. http://www.retinalphysician.com/articleviewer.aspx?articleid=1034552. Caldwell DR, Kastl PR, Cook J, Simon J. Povidone-iodine: its efficacy as a preoperative conjunctival and periocular preparation. Ann Ophthalmol. 1984;16: 577, 580.3. Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye In ophthalmic surgery. III. Effect of povldone-iodlne on the conjunctiva. Arch Ophthalmol. 1984;102:728-729.4. Isenberg SJ, Apt L, Yoshimorl R, Khwarg S. Chemical preparation of the eye In ophthalmic surgery. IV Comparison of povldone-iodlne on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103:1340-1342.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems